Continuous Glucose Monitoring Devices Market was valued at US$ 5.89 Bn in 2024 and is to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9%.

The data is sent to smartphones and can be shared with physicians or data centers. For people with diabetes, continuous ...

Then it can be shared with doctors or analyzed by computers anywhere in the world. Continuous glucose monitoring (CGM) sensors are another important IoT device. They help people with diabetes track ...

The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom ...

What if the devices you wear daily could not only enhance your productivity but also monitor your health, track your ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A ...

With data 'locked' in medical devices, sociologist Shane O'Donnell explains how people with Type 1 diabetes are turning to ...

PRNewswire Mumbai Maharashtra [India] 10 Taiwan Excellence the globally recognized symbol for Taiwanese innovation has ...

The new guidance includes updates on diabetes technology use, GLP-1 receptor agonists, liver disease, drinking water, and ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...